Hypersensitivity reactions to teniposide in children.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013713:Teniposide; D011034:Podophyllotoxin